The Footnote

The Footnote | Special Investigation “From Podiatric Surgeon to Surgical Podiatrist: Who asked for this—and who benefits?”

Author attribution not recorded

Two title signs face off across a table, symbolizing a bureaucratic title debate.

At-a-glance

  • Australia’s Health Ministers have been advised off the back of an “independent review”to change the protected specialist title from podiatric surgeon to surgical podiatrist. The Podiatry Board of Australia (the Board) and Ahpra accepted the review’s 14 recommendations and ran a national consultation in late 2024 seeking ministerial approval for the title change.

  • The review (Paterson, March 2024) did not find systemic training failures or inferior outcomes for podiatric surgeons; it reported a generally good standard of care, with notifications concentrated in a small number of practitioners. It nevertheless recommended a title change mainly to reduce public confusion about whether podiatric surgeons are medical practitioners.

  • The review was commissioned by the regulator, not published in a peer-reviewed journal. Public transparency came via a consultation paper, 130 written submissions (many published), ~70 stakeholder meetings and consumer focus groups, a policy review process, not academic peer review.

  • The AMA, RACS and AOA/AOFAS have for years lobbied against recognition of podiatric surgery as a specialty and pushed to remove the word “surgeon” from non-medical titles; momentum strengthened by the 2023 National Law amendments restricting the medical use of “surgeon.”

  • A peer-reviewed counter-view in Australian Health Review argued the proposed change lacks evidence and runs against broader health-system reform goals that favour team-based, scope-of-practice-aligned titles.

What just happened?

In March 2024, the Board and Ahpra released the Independent review of the regulation of podiatric surgeons in Australia, authored by Emeritus Professor Ron Paterson, with an Expert Advisory Group. The Board and Ahpra accepted all 14 recommendations, including a proposal to change the protected specialist title from podiatric surgeon to surgical podiatrist, arguing it would reduce consumer confusion. A national public consultation ran to 8 November 2024 to inform Health Ministers’ decision-making.

Critically, the same review states that podiatric surgeons provide a good standard of care, and that the elevated notification rate is concentrated among a few practitioners—not evidence of poor systemic training or inferior outcomes.

So why the title change? The review’s central rationale is public understanding: many people reportedly assume anyone using “surgeon” is a medical doctor. The recommended fix is a title that flags the profession first (“podiatrist”) and the surgical scope second (“surgical”), hence surgical podiatrist.

Independence & transparency: Was the review truly “independent”?

Who commissioned it, and who advised it?

The review was commissioned by the Podiatry Board of Australia and Ahpra, i.e., the same regulators who would be implementing any changes. The reviewer, Prof Ron Paterson (University of Auckland/Melbourne Law School), is an internationally respected health-law and complaints-system expert with prior ombuds roles. He was supported by an Expert Advisory Group that included a Medical Board community member, a senior adviser from the Australian Commission on Safety and Quality in Health Care, the National Health Practitioner Ombudsman, and the President of the Podiatry Council of NSW.

What this means:

Independence here means the reviewer was external to the Board/Ahpra and used open evidence and stakeholder input.

It does not mean academic peer review; this was a regulatory/policy review, not a journal article. The process emphasised consultation (130 submissions, 70+ meetings, consumer focus groups) and transparency through published submissions and public documentation. The Board’s public consultation paper documented options (retain vs change title), justification, and a route to seek Health Ministers’ approval; again, a policy pathway.

Was it peer-reviewed?

No. The Paterson report is a commissioned public review, not published in a peer-reviewed scientific journal. The most prominent peer-reviewed commentary on the title question is a 2024 Australian Health Review article arguing the change lacks evidentiary basis and conflicts with reform directions that prioritise collaborative, scope-aligned care.

Follow the timeline: How did we get here?

1970s–1990s: Historically, variations of podiatry surgical titles have been used; precise dates vary by jurisdiction

2010: Health Ministers approve specialist registration in podiatric surgery under the National Scheme with protected title “podiatric surgeon.”

2010s–2020s: Opposition from segments of the medical profession (AMA, RACS, AOA/AOFAS) continues, citing safety and title confusion.

2023: National Law amended to protect the title “surgeon” within the medical profession (cosmetic surgery reforms), only doctors in surgery, ophthalmology, or obstetrics & gynaecology may use “surgeon.” Non-medical specialist titles (e.g., podiatric surgeon, oral surgeon) remained recognised under other parts of the law.

Oct 2023–Mar 2024: Paterson review runs; report published March 2024, Board/Ahpra accept all 14 recommendations including a title change proposal.

Sep–Nov 2024: National public consultation on changing the protected title to something like “surgical podiatrist.”

2025: Ongoing regulatory follow-ups (e.g., further consultations on performance framework tweaks). Board communications indicate ministers have considered the title question following consultation.

Who are the power players?

Podiatry Board of Australia / Ahpra – Commissioned the review, accepted its recommendations, ran the public consultation, and sought Health Ministers’ approval for the title change.

Health Ministers’ Meeting (HMM) – Ultimately decide on protected titles under the National Law. (Communiqués record regulatory decisions across professions; the title question appears in the Board’s submissions/consultation funnel to Ministers.)

AMA (Australian Medical Association) – Advocated to remove “surgeon” from non-medical titles; explicit submissions opposing “podiatric surgeon” and later opposing the proposed “surgical podiatrist.”

RACS (Royal Australasian College of Surgeons) – Opposed “surgical podiatrist,” argued for public safety clarity around “surgeon.”

AOA/AOFAS (Orthopaedics) – Longstanding opposition to podiatric surgery recognition; suggested alternatives like “operative podiatrist.”

Australian Health Review (peer-reviewed) – Published critique that the evidence base for title change is weak and misaligned with collaborative-care reform.

The Paterson report itself acknowledges the “trenchant” campaign history by parts of the medical profession against podiatric surgery recognition and warns that in this context of professional rivalry, notification data need careful interpretation.

What the evidence actually says (and doesn’t)

Training & outcomes. The review did not substantiate claims that Australian podiatric surgeons are inadequately trained or systemically unsafe. It recommended some accreditation refinements (e.g., surgical experts on site teams, standards for training sites) but concluded concerns about training “are not supported by the evidence examined.” Notifications were driven mainly by individual clinical decision-making among non-recent graduates and a few frequently-notified practitioners.

Title confusion. The centerpiece rationale for change is consumer understanding: the public reportedly assumes “surgeon” = medical doctor. The report argues that surgical podiatrist keeps scope clarity while signalling profession—podiatry—up front.

But is there high-quality evidence that a title change improves safety or comprehension? That’s the weak link. The peer-reviewed critique in Australian Health Review says the case for changing the title lacks evidence and could run counter to health-system reforms encouraging clear scopes, better access and collaborative care.

Transparency. On process, the review and Board did make submissions and consultation outputs public, including options papers and a “snapshot” explainer, strong on procedural transparency, but again, not a scientific peer-review.

Cui bono? (Who benefits?)

Short answer

A title change from podiatric surgeon to surgical podiatrist most obviously serves stakeholders who have campaigned to confine the word “surgeon” to medicine; the AMA, RACS and AOA/AOFAS; by aligning language with the 2023 National Law amendments that protected “surgeon” within the medical profession.

Given the documented positions of AMA/RACS/AOFAS, a title change would align with their advocacy to reserve ‘surgeon’ for medical specialists.

Longer answer

  • It arguably reduces friction with those groups and symbolically reinforces hierarchical, profession-first naming conventions.

  • For the public, the review asserts it reduces confusion, but offers no robust, peer-reviewed evidence that a relabelling without broader public education materially improves safety or decision-making.

  • For access & workforce, the risk (as flagged by peer-reviewed commentary) is that de-emphasising “surgeon” may inadvertently signal lesser capability, potentially undermining referrals, commissioning and public-system integration, especially in regional areas already short of foot & ankle surgical capacity.

The naming problem we’re not solving

Australia just tightened the medical use of “surgeon” after the cosmetic surgery scandals; the National Law now restricts who, among doctors, may use the title. That reform, however, explicitly left untouched specialist titles for non-medical professions (e.g., podiatric and oral surgery) because they’re recognised under separate parts of the National Law.

Against that backdrop, the push to remove “surgeon” from podiatry looks less like a neutral clarity exercise and more like a spillover of medical title politics into allied health, especially given the decades-long campaigns recorded in the Paterson report.

If our real goal is clear consumer information, we could:

Standardise title modifiers across professions ([profession] surgical specialist),

Mandate plain-language signage/consent that explains training pathways and how scopes overlap and differ, and

Publish comparable outcomes dashboards for foot & ankle surgery across providers (orthopaedic and podiatric), rather than tweak a label and declare victory.

None of those require erasing “surgeon” from a non-medical specialty’s title.

International context (quick scan)

The review surveyed UK, US, Canada, NZ arrangements; it did not find slam-dunk evidence that Australia’s podiatric surgeons are out of step on training/competence. It recommended strengthening accreditation (e.g., surgical expertise on teams, training site standards), not dismantling the specialty. The title confusion argument is largely Australian and tied to our National Law’s structure and political history.

Fairness test: what the review got right

Called out rivalry: It openly notes “trenchant” opposition from parts of the medical profession and cautions against naïve readings of notification data in such a context.

Backed training quality: It found no evidence of systemic training failure and pointed to contemporary accreditation standards.

Proposed practical fixes: Better accreditation processes, clearer advertising rules, and a stronger performance framework are all sensible.

Where it overreaches is the leap from “some consumers are confused” to “therefore, strip the word surgeon from a non-medical, legally recognised surgical specialty’s title.” That’s a policy preference, not an evidence-based necessity—and it carries system-level trade-offs the report does not quantify.

Questions Health Ministers should have to answer (before locking in the change)

  1. Evidence of benefit: What peer-reviewed evidence shows a title change delivers measurable safety or comprehension gains vs. alternatives (consumer education, consent, signage, outcomes transparency)?

  2. Equity & access: What modelling has been done on regional surgical access if commissioning/payer networks read a down-tier signal from the new title? (The review itself records that public-system integration has been politically resisted.)

  3. Consistency across professions: If the logic is “profession first, scope second,” will this be consistently applied across the National Scheme or only to podiatry? Where is the whole-of-scheme framework?

  4. Alternatives considered: Why not keep “podiatric surgeon” and instead mandate plain-English disclosures about training pathways at first contact and on websites? Where is the trial-evidence?

  5. Cost/transition impacts: What’s the cost (re-credentialing, signage, legal documents, public education) and who pays? Where’s the transition plan beyond changing letterheads?

A constructive alternative package

If the goal is genuine public protection and clarity, here’s a three-part package that would do more than relabel stationery:

Truth-in-Titles Plus: Keep podiatric surgeon (or permit dual titling Surgical Podiatrist (Podiatric Surgeon)) while requiring standardised consumer disclosures about training/registration pathways; audit compliance in advertising and consent.

Outcomes Transparency: Publish risk-adjusted, procedure-level outcomes dashboards for foot & ankle surgery across settings and professions; make them patient-facing and referral-facing. (The review already points to strengthening performance frameworks.)

Accreditation Upgrades: Implement the review’s accreditation recommendations (surgical expertise on assessment teams; training site standards), with joint orthopaedic–podiatric panels to defuse rivalry and centre patient safety.

This approach targets the risk (information asymmetry, pockets of poor practice) without imposing a profession-politics solution (title erasure) that lacks robust outcome evidence.

The stakes for consumers and the system

Consumers deserve clear, plain-language information about who is treating them and how that practitioner is trained and regulated. A label change that sounds smaller could unintentionally limit access, especially outside metro areas, without delivering material safety gains.

Clinicians across professions need inter-professional trust frameworks. The review’s own history recounts decades of rivalry; a title change that feels like a win for one camp risks entrenching silos.

Policy-makers should choose measurable interventions first. If comprehension is the problem, measure comprehension before and after targeted consumer-education interventions, not just after a label swap.

Bottom line

This decision is less about safety evidence and more about political semiotics: who gets to wear the word surgeon. The peer-reviewed critique says the change lacks evidence and may cut against integrated care reforms. The regulator’s own review found no systemic training deficit and a generally good standard of care, yet recommends a title change primarily to address perception.

Changing a word is easy. Changing outcomes takes work.

If Health Ministers’ aim is public protection, the smarter path is Truth-in-Titles Plus, transparent outcomes, and accreditation muscle, not a one-way title downgrade that conveniently aligns with long-running professional lobbying.

Sources & key documents

Independent review of the regulation of podiatric surgeons (Paterson, March 2024): findings, history, recommendations.

Board/Ahpra public consultation on title change (options, rationale, timeline).

Board notices accepting the recommendations and seeking Ministers’ approval.

AMA/RACS/AOA submissions and statements opposing “podiatric surgeon” and “surgical podiatrist.”

National Law (Surgeons) Amendment Act 2023 and regulator FAQs (medical title restriction).

Australian Health Review peer-reviewed critique of title change proposal.

Author’s note

This investigative is published under The Footnote to inform clinicians, policymakers and the public. If you’ve read the review or made a submission and think we’ve missed a crucial angle, drop it in the comments (with links), and we’ll examine it in a follow-up.

Simplified complete reading view